MedTrace Logo

Corneal Endothelial Cell Injury Induced by Mitomycin-C

NCT05548478 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2022-09-21

No results posted yet for this study

Summary

our study will investigate the effecacy of Mitomycin-C in TransEpi single step photorefractive keratectomy (PRK) and alcohol assisted PRK

Conditions

  • Myopia

Interventions

PROCEDURE

Transepithelial PRK/MMC

transepithelial photorefractive keratectomy (PRK) and mitomycin C addition

PROCEDURE

Alcohol-Assisted PRK/MMC

photorefractive keratectomy (PRK) assisted by alchol and mitomycin C addition

Sponsors & Collaborators

  • Al-Azhar University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
17 Years
Max Age
50 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-09-30
Primary Completion
2023-02-28
Completion
2023-02-28

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05548478 on ClinicalTrials.gov